Skip to Main Content

Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin (ASTROH)

Conditions

Diseases of the Cardiovascular System

Phase II

What is the purpose of this trial?

A Blind-adjudication Multi-center Phase II Randomized Clinical Trial of Continuous Low-dose Intravenous Heparin Therapy in Coiled Low-grade Aneurysmal Subarachnoid Hemorrhage Patients with Significant Hemorrhage Burden.

  • Trial with
    University of Louisville
  • Start Date
    05/31/2017
  • End Date
    01/31/2018
Trial Image

For more information about this study, contact:

Lindsey Fraczkiewicz

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    02/22/2018
  • Study HIC
    #1601017127